InsidersTradesSigma
Track the 特宝生物 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 特宝生物 has logged 5 insider filings. Market capitalisation: €23.7bn. The latest transaction was filed on 15 July 2024 (Sale). Among the most active insiders: 王君业. All data is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
5 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,673 of 29,064 companies
69.3
score / 100
Value46
Quality93
FCF yld2.0%
Earn yld4.3%
EV/EBITDA18.4x
ROE32%
Gross mgn93%
Net mgn28%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 July 2024
Declarations5 total
5 of 5 declarations
Acerca de 特宝生物
特宝生物 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la Bolsa de Shanghái. Se enfoca en el desarrollo y la comercialización de productos biofarmacéuticos.